Anlon Healthcare Ltd vs Paragon Fine And Speciality Chemical Ltd Stock Comparison
Anlon Healthcare Ltd vs Paragon Fine And Speciality Chemical Ltd Stock Comparison
Last Updated on: Mar 30, 2026
Key Highlights
The Latest Trading Price of Anlon Healthcare Ltd is ₹ 111.3 as of 30 Mar 15:30
. The P/E Ratio of Anlon Healthcare Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Paragon Fine and Speciality Chemical Ltd changed from 15.2 on March 2024 to 21.6 on March 2025 . This represents a CAGR of 19.21% over 2 years The Market Cap of Anlon Healthcare Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Paragon Fine and Speciality Chemical Ltd changed from ₹ 216.99 crore on March 2024 to ₹ 127.86 crore on March 2025 . This represents a CAGR of -23.24% over 2 years The revenue of Anlon Healthcare Ltd for the Dec '25 is ₹ 35.78 crore as compare to the Sep '25 revenue of ₹ 52.23 crore. This represent the decline of -31.5% The revenue of Paragon Fine and Speciality Chemical Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Anlon Healthcare Ltd for the Dec '25 is ₹ 12.54 crore as compare to the Sep '25 ebitda of ₹ 13.77 crore. This represent the decline of -8.93% The ebitda of Paragon Fine and Speciality Chemical Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Anlon Healthcare Ltd changed from ₹ 4.54 crore to ₹ 5.15 crore over 7 quarters. This represents a CAGR of 7.47%
The net profit of Paragon Fine and Speciality Chemical Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0%
The Dividend Payout of Anlon Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Paragon Fine and Speciality Chemical Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .
About Anlon Healthcare Ltd
Anlon Healthcare Limited was originally incorporated as 'Anlon Ventures Private Limited', dated November 19, 2013 issued by the RoC. The Company changed the name from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited' and a fresh Certificate of Incorporation dated May 27, 2015 was issued by the RoC. The status of the Company was subsequently converted to a Public Limited and the name of the Company was changed to 'Anlon Healthcare Limited' dated September 2, 2024 by the RoC.
Anlon Healthcare is engaged in manufacturing of Pharma Intermediates and APIs.
They are one of the few manufacturers of loxoprofen sodium dihydrate in India, a notable API , widely used in treatment of pain/inflammation association with conditions including rheumatoid arthritis, osteoarthritis, lower back pain, frozen shoulder, neck-shoulder-arm syndrome, tooth pain or after surgery, injury or tooth extraction.
About Paragon Fine and Speciality Chemical Ltd
Paragon Fine & Speciality Chemicals Limited was originally formed as Partnership Firm under the Indian Partnership Act, 1932 in the name and style of 'M/s.
Devarshi Dyechem', pursuant to a Deed of Partnership dated February 02, 2003.
Thereafter, the name of the said Partnership Firm was changed to M/s.
Paragon Industries.
Further, 'M/s Paragon Industries' converted from Partnership Firm to a Private Limited Company in the name of 'Paragon Fine and Speciality Chemical Private Limited' vide Certificate of Incorporation dated November 02, 2018 issued by Registrar of Companies, Central Registration Centre.
FAQs for the comparison of Anlon Healthcare Ltd and Paragon Fine and Speciality Chemical Ltd
Which company has a larger market capitalization, Anlon Healthcare Ltd or Paragon Fine and Speciality Chemical Ltd?
Market cap of Anlon Healthcare Ltd is 591 Cr while Market cap of Paragon Fine and Speciality Chemical Ltd is 69 Cr
What are the key factors driving the stock performance of Anlon Healthcare Ltd and Paragon Fine and Speciality Chemical Ltd?
The stock performance of Anlon Healthcare Ltd and Paragon Fine and Speciality Chemical Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Anlon Healthcare Ltd and Paragon Fine and Speciality Chemical Ltd?
As of March 30, 2026, the Anlon Healthcare Ltd stock price is INR ₹111.3. On the other hand, Paragon Fine and Speciality Chemical Ltd stock price is INR ₹35.6.
How do dividend payouts of Anlon Healthcare Ltd and Paragon Fine and Speciality Chemical Ltd compare?
To compare the dividend payouts of Anlon Healthcare Ltd and Paragon Fine and Speciality Chemical Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.